Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo

Title
Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo
Authors
Keywords
FOXO3, breast cancer, bepridil, trifluoperazine, dopamine receptor
Journal
Oncotarget
Volume 7, Issue 27, Pages -
Publisher
Impact Journals, LLC
Online
2016-06-07
DOI
10.18632/oncotarget.9881

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started